Dong-A ST Applies for Phase 3 Clinical Trial of Chronic Plaque Psoriasis Treatment
[Asia Economy Reporter Gong Byung-sun] Dong-A ST announced on the 23rd that it has applied for approval of the Phase 3 clinical trial plan for the chronic plaque psoriasis treatment DMB-3115 from the clinical approval institution Georgia BIOMAPAS.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- One in 77 Koreans Exposed to Drugs... Enough Money for 6,600 Luxury Gangnam Apartments Circulates in Drug Market [ChwiYakGukga] ⑩
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Dong-A ST explained that the statistical probability of the clinical trial drug receiving final approval is about 10%, and therefore investment should be made cautiously.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
